New study reveals new drug target for gout & inflammatory diseases
Research reveals cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease…
List view / Grid view
Research reveals cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease…
Scientists have discovered a link between a major mechanism of antibiotic resistance and resistance to the common disinfectant triclosan...
Research from King’s College in London, UK, and Lund University in Sweden could explain why diabetes drugs that have worked in animal experiments are not equally successful in humans. The researchers discovered differences – as well as hitherto unknown similarities – in the function of insulin-producing beta cells.
30 June 2017 | By PerkinElmer
In this webinar, PerkinElmer and AMRI will present a case study wherein high-performance computing (HPC) was leveraged for enhanced performance in image and data analysis of High Content Screening experiments...
University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face - antibiotic resistance.
A mixed reality system which allows medical practitioners to view and interact with virtual replicas of patients’ organs, bones or body parts is being developed by academics.
Radisens Diagnostics, an Irish medtech business, is aiming to raise £22 million to bring its innovative diabetes management platform to market...
NIH-supported research suggests potential treatment strategy following the identification of single-gene mutations that lead to eczema.
Elsevier has launched a new solution aimed at accelerating drug discovery through comprehensive prediction and assessment of drug-drug interactions (DDI).
AMI has released the full version of HCC Coding as part of the EMscribe suite of tools in support of medical records processing and abstraction.
The ABPI has developed a new tool to help build research relationships between the pharmaceutical industry and UK academics.
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
Researchers have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease.
Researchers at The Australian National University (ANU) are working on a new treatment for an aggressive type of leukaemia that outperforms standard chemotherapies.
Sophia Genetics injects artificial intelligence in liquid biopsies to accelerate early detection of cancer and monitor treatments’ effectiveness.